title: mBio addresses the pause in gain-of-function (GOF) experiments involving pathogens with pandemic potential (PPP).
authors.affiliation: Department of Microbiology & Immunology, Albert Einstein College of Medicine, Bronx, New York, USA casadeva@aecom.yu.edu.
authors.forename: Arturo
authors.initials: A
authors.lastname: Casadevall
authors.affiliation: Department of Molecular Biology, Princeton University, Princeton, New Jersey, USA.
authors.forename: Thomas
authors.initials: T
authors.lastname: Shenk
mesh_terms: D035843:Biomedical Research / Q000639:trends*; D006291:Health Policy; D006801:Humans; D065207:Middle East Respiratory Syndrome Coronavirus / Q000235:genetics / Q000276:immunology / Q000472:pathogenicity*; D009975:Orthomyxoviridae / Q000235:genetics / Q000276:immunology / Q000472:pathogenicity*; D058873:Pandemics / Q000517:prevention & control*; D011995:Recombination, Genetic; D045473:Severe acute respiratory syndrome-related coronavirus / Q000235:genetics / Q000276:immunology / Q000472:pathogenicity*; D014481:United States; D014774:Virulence